Journey Medical Corporation (DERM) Stock

Journey Medical Corporation, headquartered in Scottsdale, Arizona, specializes in the development and distribution of pharmaceutical products tailored for the treatment of dermatological conditions across the United States. Renowned for its comprehensive portfolio, the company markets a range of therapeutic solutions that address various skin ailments. These include Qbrexza, an innovative medicated cloth towelette designed to manage primary axillary hyperhidrosis, a condition characterized by excessive sweating. Additionally, Journey Medical offers well-established treatments such as Accutane, an oral isotretinoin medication known for its efficacy in treating severe recalcitrant acne, alongside Targadox and Ximino, oral antibiotics used adjunctively for severe and moderate to severe acne, respectively. The company also provides Exelderm cream and solution for topical dermatologic use, along with a selection of doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.

Founded as Coronado Dermatology, Inc. and later rebranded as Journey Medical Corporation, the company has steadily expanded its footprint in the dermatological pharmaceutical market since its inception in 2014. Journey Medical remains committed to enhancing patient care by continuously advancing its product offerings and exploring new avenues for innovation in dermatologic treatments. With a focus on quality and efficacy, Journey Medical Corporation continues to play a pivotal role in shaping the landscape of dermatological healthcare through its diverse and clinically proven therapeutic options.